Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001188919-26-000015
Filing Date
2026-09-02
Accepted
2026-09-02 17:28:35
Documents
1
Period of Report
2026-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4755
  Complete submission text file 0001188919-26-000015.txt   6481
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
LOVE TED W (Reporting) CIK: 0001188919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 261356056

Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)